MTOR and astrocytoma (excluding glioblastoma): Dysregulation of mTOR signaling was found to underlie the development of subependymal giant cell astrocytomas in tuberous sclerosis, which provided a basis for logical strategies for mTOR-directed molecular-targeted therapy [22,23].